Silver Coast Investments’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Silver Coast Investments's ABBV Position: Q2 2026 in Review
Silver Coast Investments increased its AbbVie (ABBV) stake by 7.9% in Q2 2026, buying an estimated $34.6K and bringing the position to 2,210 shares worth $556K. The position accounts for 0.17% of the portfolio, ranked #64.
Silver Coast Investments first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 2,417 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Silver Coast Investments held 2,210 shares of AbbVie worth $556K as of Q2 2026.
- Silver Coast Investments bought 161 AbbVie shares in Q2 2026, an estimated $34.6K.
- AbbVie made up 0.17% of Silver Coast Investments's portfolio in Q2 2026, its #64 holding.
- Silver Coast Investments first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
- 2,417 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Silver Coast Investments's 13F filing for Q2 2026, filed 24 Jul 2026.